Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Yuxi Gong, Haitao Yan, Yefan Yang, Boya Zhai, Zhendong Huang & Zhihong Zhang. (2023) Construction and Validation of a Novel Nomogram for Predicting the Recurrence of Diffuse Large B Cell Lymphoma Treated with R-CHOP. Pharmacogenomics and Personalized Medicine 16, pages 291-301.
Read now
Read now
Jingjing Ma, Qing Li, Jie Shao, Yan Ma, Zhiguang Lin, Hui Kang & Bobin Chen. (2019) Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study. Cancer Management and Research 11, pages 10175-10185.
Read now
Read now
Nicola Lehners, Isabelle Krämer, Mark-Alexander Schwarzbich, Anthony D. Ho & Mathias Witzens-Harig. (2016) Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era. Leukemia & Lymphoma 57:11, pages 2619-2625.
Read now
Read now
Carrie van der Weyden & H. Miles Prince. (2016) High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from “orphan drug” to a standard-of-care?. Leukemia & Lymphoma 57:1, pages 1-3.
Read now
Read now
Isabelle Fleury, Sandy Amorim, Nicolas Mounier, Bertrand Coiffier, Jehan Dupuis, Hervè Tilly, Mohamed A. Mazari, Lauriane Filliatre, Josette Brière, Pauline Brice, Eric de Kerviler & Catherine Thieblemont. (2015) Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study. Leukemia & Lymphoma 56:7, pages 2025-2031.
Read now
Read now
Mark Roschewski & Kieron Dunleavy. (2015) Secondary diffuse large B-cell lymphoma of the central nervous system: the need for better predictors. Leukemia & Lymphoma 56:6, pages 1583-1584.
Read now
Read now
Naoto Tomita, Hirotaka Takasaki, Yasufumi Ishiyama, Kumiko Kishimoto, Daisuke Ishibashi, Satoshi Koyama, Yoshimi Ishii, Hiroyuki Takahashi, Ayumi Numata, Reina Watanabe, Takayoshi Tachibana, Rika Ohshima, Maki Hagihara, Chizuko Hashimoto, Sachiya Takemura, Jun Taguchi, Katsumichi Fujimaki, Rika Sakai, Shigeki Motomura & Yoshiaki Ishigatsubo. (2015) Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone. Leukemia & Lymphoma 56:3, pages 725-729.
Read now
Read now
Christopher D. Fletcher & Brad S. Kahl. (2014) Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era. Leukemia & Lymphoma 55:10, pages 2228-2240.
Read now
Read now
Chan Y. Cheah & John F. Seymour. (2014) Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?. Leukemia & Lymphoma 55:3, pages 471-473.
Read now
Read now
Articles from other publishers (38)
Septiara Putri, Ery Setiawan, Siti Rizny F. Saldi, Levina Chandra Khoe, Euis Ratna Sari, Amila Megraini, Mardiati Nadjib, Sudigdo Sastroasmoro & Armansyah Armansyah. (2022) Adding rituximab to chemotherapy for diffuse large B-cell lymphoma patients in Indonesia: a cost utility and budget impact analysis. BMC Health Services Research 22:1.
Crossref
Crossref
Nianhai Zhang, Deming Xu, Bo Liu, Xi Shi, Xianhe Xie & Zili Wang. (2022) Prophylaxis strategies containing high dose intravenous methotrexate on preventing CNS relapse for patients with diffuse large B-cell lymphoma at intermediate to high risk: A study based on 12 cohorts in the rituximab era. International Immunopharmacology 113, pages 109299.
Crossref
Crossref
Sabela Bobillo, Jahanzaib Khwaja, Andrés J.M. Ferreri & Kate Cwynarski. (2022) Prevention and management of secondary central nervous system lymphoma. Haematologica 108:3, pages 673-689.
Crossref
Crossref
Wenqi Zhang, Chen Huang, Ruixia Liu, Huichao Zhang, Weijing Li, Shaoning Yin, Lianjing Wang, Wei Liu & Lihong Liu. (2022) Case report: CD19-directed CAR-T cell therapy combined with BTK inhibitor and PD-1 antibody against secondary central nervous system lymphoma. Frontiers in Immunology 13.
Crossref
Crossref
Zhijuan Lin, Xing Chen, Long Liu, Hanyan Zeng, Zhifeng Li & Bing Xu. (2022) The role of central nervous system (CNS) prophylaxis in preventing DLBCL patients from CNS relapse: A network meta-analysis. Critical Reviews in Oncology/Hematology 176, pages 103756.
Crossref
Crossref
Kota Yokoyama, Jun Oyama, Junichi Tsuchiya, Jun Karakama, Kaoru Tamura, Motoki Inaji, Yoji Tanaka, Daisuke Kobayashi, Taketoshi Maehara & Ukihide Tateishi. (2022) Branch-like enhancement on contrast enhanced MRI is a specific finding of cerebellar lymphoma compared with other pathologies. Scientific Reports 12:1.
Crossref
Crossref
Guiyi Ho, Cherie Tan, Sanjay de Mel, Limei Poon, Esther H.L. Chan, Joanne Lee, Xin Liu, Wee Joo Chng, Yen Lin Chee, Yu Yang Soon & Anand D. Jeyasekharan. (2021) Central nervous system (CNS) prophylaxis in antiCD20-CHOP treated DLBCL at intermediate to high risk for CNS relapse: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 167, pages 103507.
Crossref
Crossref
Mohammad Ma'koseh, Faris Tamimi, Alaa Abufara, Lana Abusalem, Osama Salama, Jacob Saleh, Rnad Khader, Baha A Faiyoumi, Mohammad Al-Rwashdeh & Khaled Halahleh. (2021) Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma. Cureus.
Crossref
Crossref
XiaoQin Wu, XinYue Zhang, RenDe Xun, MengSi Liu, Zhen Sun & JianChao Huang. (2021) Efficacy and Safety of Axicabtagene Ciloleucel and Tisagenlecleucel Administration in Lymphoma Patients With Secondary CNS Involvement: A Systematic Review. Frontiers in Immunology 12.
Crossref
Crossref
Jun Ho Yi, Sang Eun Yoon, Kyung Ju Ryu, Young Hyeh Ko, Won Seog Kim & Seok Jin Kim. (2020) Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma. Cytokine 129, pages 155048.
Crossref
Crossref
Melissa J. Garwood, Eliza A. Hawkes, Leonid Churilov & Geoffrey Chong. (2019) Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma. Cancer Chemotherapy and Pharmacology 85:1, pages 133-140.
Crossref
Crossref
Yuchen Wu, Yaming Wang, Xuefei Sun, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Ruixian Xing, Yuedan Chen, Qing Liu, Jiayuan Guo, Nan Ji, Shengjun Sun & Yuanbo Liu. (2019) Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population. BMC Neurology 19:1.
Crossref
Crossref
Roopesh Kansara. (2018) Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma. Current Treatment Options in Oncology 19:11.
Crossref
Crossref
Thomas A. Ollila & Adam J. Olszewski. (2018) Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence. Current Treatment Options in Oncology 19:8.
Crossref
Crossref
Ayed O. Ayed, Annalisa Chiappella, Levi Pederson, Betsy R. Laplant, Angela Giovanna Congiu, Gianluca Gaidano, Michele Spina, Alessandro Re, Federica Cavallo, Gerardo Musuraca, William R. Macon, Thomas Witzig, Umberto Vitolo & Grzegorz S. Nowakowski. (2018) CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies. Blood Cancer Journal 8:7.
Crossref
Crossref
Haorui Shen, Zhang Wei, Daobin Zhou, Yan Zhang, Xiao Han, Wei Wang, Lu Zhang, Chen Yang & Jun Feng. (2018) Primary extra‑nodal diffuse large B‑cell lymphoma: A prognostic analysis of 141 patients. Oncology Letters.
Crossref
Crossref
Marcel Nijland, Karin Boslooper, Gustaaf van Imhoff, Robbie Kibbelaar, Peter Joosten, Huib Storm, Eric N. van Roon, Arjan Diepstra, Hanneke C. Kluin-Nelemans & Mels Hoogendoorn. (2018) Relapse in stage I(E) diffuse large B-cell lymphoma. Hematological Oncology 36:2, pages 416-421.
Crossref
Crossref
De Zhou, Changqian Bao, Xiujin Ye, Lixia Zhu, Jingjing Zhu, Li Li, Mingyu Zhu, Xiudi Yang, Yanlong Zheng, Xianbo Huang, Mixue Xie & Wanzhuo Xie. (2017) Clinical and histological features of primary testicular diffuse large B-cell lymphoma: a single center experience in China. Oncotarget 8:68, pages 112384-112389.
Crossref
Crossref
Kerry J. Savage. (2017) Secondary CNS relapse in diffuse large B-cell lymphoma: defining high-risk patients and optimization of prophylaxis strategies. Hematology 2017:1, pages 578-586.
Crossref
Crossref
E. Gardette, A. Maraval, F. Brunet-Possenti, G. Quereux, H. Beltraminelli, I. Templier, J. Hodel, E. Scherman, E. Durot, M. Bagot, A. Pham-Ledard, F. Grange, M. Beylot-Barry & S. Ingen-Housz-Oro. (2017) Central nervous system involvement of primary cutaneous diffuse large B-cell lymphoma, leg type: 13 cases. Journal of the European Academy of Dermatology and Venereology 31:11, pages e498-e501.
Crossref
Crossref
M. Gleeson, N. Counsell, D. Cunningham, N. Chadwick, A. Lawrie, E.A. Hawkes, A. McMillan, K.M. Ardeshna, A. Jack, P. Smith, P. Mouncey, C. Pocock, J.A. Radford, J. Davies, D. Turner, A. Kruger, P. Johnson, J. Gambell & D. Linch. (2017) Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial. Annals of Oncology 28:10, pages 2511-2516.
Crossref
Crossref
Collin K. Chin & Chan Yoon Cheah. (2017) How I treat patients with aggressive lymphoma at high risk of CNS relapse. Blood 130:7, pages 867-874.
Crossref
Crossref
Monika Motyčková, Vladimíra Vosáhlová, David Belada, Martin Šimkovič & Pavel Žák. (2017) Primary testicular lymphoma. Vnitřní lékařství 63:6, pages 415-422.
Crossref
Crossref
Edurne Sarrate, Marc Sorigue, Miriam Carbajal, Inmaculada Portal, Juan-Manuel Sancho & Jordi Juncà. (2016) Late isolated intraocular relapse of a systemic diffuse large B-cell lymphoma detected by flow cytometry. Annals of Hematology 96:3, pages 523-524.
Crossref
Crossref
Robert Kridel, David Telio, Diego Villa, Laurie H. Sehn, Alina S. Gerrie, Tamara Shenkier, Richard Klasa, Graham W. Slack, King Tan, Randy D. Gascoyne, Joseph M. Connors & Kerry J. Savage. (2016)
Diffuse large B‐cell lymphoma with testicular involvement: outcome and risk of
CNS
relapse in the rituximab era
. British Journal of Haematology 176:2, pages 210-221.
Crossref
Crossref
Kitsada Wudhikarn, Udomsak Bunworasate, Jakrawadee Julamanee, Arnuparp Lekhakula, Suporn Chuncharunee, Pimjai Niparuck, Supachai Ekwattanakit, Archrob Khuhapinant, Lalita Norasetthada, Weerasak Nawarawong, Nisa Makruasi, Nonglak Kanitsap, Chittima Sirijerachai, Kanchana Chansung, Peerapon Wong, Tontanai Numbenjapon, Kannadit Prayongratana, Tawatchai Suwanban, Somchai Wongkhantee, Pannee Praditsuktavorn & Tanin Intragumtornchai. (2016) Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry. Annals of Hematology 96:1, pages 57-64.
Crossref
Crossref
Qing-Qing Cai, Li-Yang Hu, Qi-Rong Geng, Jie Chen, Zhen-Hai Lu, Hui-Lan Rao, Qing Liu, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin & Zhong-Jun Xia. (2016) New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study. Chinese Journal of Cancer 35:1.
Crossref
Crossref
Seok Jin Kim, Jun Sik Hong, Myung Hee Chang, Jeong-A Kim, Jae-Yong Kwak, Jin Seok Kim, Dok Hyun Yoon, Won Sik Lee, Young Rok Do, Hye Jin Kang, Hyeon-Seok Eom, Yong Park, Jong-Ho Won, Yeung-Chul Mun, Hyo Jung Kim, Jung Hye Kwon, Jee Hyun Kong, Sung Yong Oh, Sunah Lee, Sung Hwa Bae, Deok-Hwan Yang, Hyun Jung Jun, Yang Soo Kim, Hwan Jung Yun, Soon Il Lee, Min Kyoung Kim, Eun Kyung Park, Won Seog Kim & Cheolwon Suh. (2016) Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study. Oncotarget 7:44, pages 72033-72043.
Crossref
Crossref
Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima & Yoshiharu Maeda. (2016) Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model. Annals of Hematology 95:10, pages 1661-1669.
Crossref
Crossref
Simone Canovi & Daniele Campioli. (2016) Accuracy of flow cytometry and cytomorphology for the diagnosis of meningeal involvement in lymphoid neoplasms: A systematic review. Diagnostic Cytopathology 44:10, pages 841-856.
Crossref
Crossref
L Deng, Z Y Xu-Monette, S Loghavi, G C Manyam, Y Xia, C Visco, J Huh, L Zhang, Q Zhai, Y Wang, L Qiu, K Dybkær, A Chiu, A M Perry, S Zhang, A Tzankov, H Rao, J Abramson, A R Sohani, M Xu, E D Hsi, J Zhu, M Ponzoni, S Wang, Ling Li, M Zhang, A J M Ferreri, B M Parsons, Y Li, M A Piris, L J Medeiros & K H Young. (2015) Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. Leukemia 30:2, pages 361-372.
Crossref
Crossref
Juan-Manuel Sancho & Josep-Maria Ribera. (2016) Recaída en el sistema nervioso central en el linfoma B difuso de célula grande: factores de riesgo. Medicina Clínica 146:2, pages 74-80.
Crossref
Crossref
Juan-Manuel Sancho & Josep-Maria Ribera. (2016) Central nervous system relapse in diffuse large B cell lymphoma: Risk factors. Medicina Clínica (English Edition) 146:2, pages 74-80.
Crossref
Crossref
Abhimanyu Ghose, Harold Kunal Elias, Gunjan Guha, Mahender Yellu, Ria Kundu & Tahir Latif. (2015) Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis—A Systematic Review of Prospective Studies. Clinical Lymphoma Myeloma and Leukemia 15:8, pages 451-457.
Crossref
Crossref
Chan Yoon Cheah & John F. Seymour. (2015) Central Nervous System Prophylaxis in Non-Hodgkin Lymphoma: Who, What, and When?. Current Oncology Reports 17:6.
Crossref
Crossref
Valentina Nardi, Olja Pulluqi, Jeremy S. Abramson, Paola Dal Cin & Robert P. Hasserjian. (2015) Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information. American Journal of Hematology 90:6, pages 529-533.
Crossref
Crossref
C Y Cheah, K E Herbert, K O'Rourke, G A Kennedy, A George, P L Fedele, M Gilbertson, S Y Tan, D S Ritchie, S S Opat, H M Prince, M Dickinson, K Burbury, M Wolf, E H Januszewicz, C S Tam, D A Westerman, D A Carney, S J Harrison & J F Seymour. (2014) A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma. British Journal of Cancer 111:6, pages 1072-1079.
Crossref
Crossref
Chan Yoon Cheah, John F Seymour & Michael Dickinson. (2014) Ongoing challenge of optimal patient selection for CNS prophylaxis in patients with non-Hodgkin lymphoma. International Journal of Hematologic Oncology 3:3, pages 189-201.
Crossref
Crossref